D. Thewke

发表

Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.

S. Michaelis, A. Rusiñol, C. Hrycyna, 2005, The Biochemical journal.

The Contribution of Endothelial-Mesenchymal Transition to Atherosclerosis

P. Musich, D. Thewke, Jinyu Zhang, 2021, International Journal of Translational Medicine.

Wnt2 Contributes to the Development of Atherosclerosis

Sanjay K. Singh, P. Musich, D. Thewke, 2021, Frontiers in Cardiovascular Medicine.

Acyl-coenzyme A:cholesterol acyltransferase promotes oxidized LDL/oxysterol-induced apoptosis in macrophages Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500101-JLR200

M. Linton, A. Rusiñol, S. Fazio, 2005, Journal of Lipid Research.

Acyl-CoA : Cholesterol Acyltransferase Promotes Oxidized LDL / Oxysterol-Induced Apoptosis in Macrophages

M. Linton, S. Fazio, D. Hachey, 2005 .

Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2.

D. Thewke, Courtney D Netherland, 2010, Biochemical and biophysical research communications.

The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus

D. Thewke, N. Seeds, 1999, Brain Research.

Transcriptional homeostatic control of membrane lipid composition.

D. Thewke, M. Sinensky, M. Kramer, 2000, Biochemical and biophysical research communications.

Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.

D. Thewke, Courtney Netherland-Van Dyke, Ward K Rodgers, 2015, Journal of cardiology and therapeutics.

AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.

D. Thewke, N. Freeman-Anderson, Courtney D Netherland, 2009, Biochemical and biophysical research communications.

Plasminogen activators and their interaction with the extracellular matrix in neural development, plasticity and regeneration

D. Thewke, N. Seeds, P. McGuire, 1996 .

Stimulation of Akt poly-ubiquitination and proteasomal degradation in P388D1 cells by 7-ketocholesterol and 25-hydroxycholesterol.

D. Thewke, M. Sinensky, June Liu, 2009, Archives of biochemistry and biophysics.

Deficiency of ataxia‐telangiectasia mutated kinase attenuates Western‐type diet‐induced cardiac dysfunction in female mice

Suman Dalal, Mahipal Singh, D. Thewke, 2022, Physiological reports.

Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice.

D. Thewke, Courtney D Netherland, Theresa G Pickle, 2010, Atherosclerosis.

Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS.

Stacy D. Brown, D. Thewke, Makenzie L. Fulmer, 2016, European journal of lipid science and technology : EJLST.

The HGF/MET Signaling and Therapeutics in Cancer

D. Thewke, Q. Xie, Makenzie L. Fulmer, 2018 .

KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells Published, JLR Papers in Press, September 14, 2005. DOI 10.1194/jlr.M500154-JLR200

Yongsheng Chang, D. Thewke, R. Mason, 2005, Journal of Lipid Research.

Functional recognition of the neuronal tyrosine hydroxylase cAMP regulatory element in different cell types.

D. Schlichter, D. Thewke, Z. Huang, 1991, Brain research. Molecular brain research.

AKT/Protein Kinase B Regulation of BCL Family Members during Oxysterol-induced Apoptosis*

A. Rusiñol, D. Thewke, M. Sinensky, 2004, Journal of Biological Chemistry.

Oleate Potentiates Oxysterol Inhibition of Transcription from Sterol Regulatory Element-1-regulated Promoters and Maturation of Sterol Regulatory Element-binding Proteins*

D. Thewke, M. Sinensky, S. Panini, 1998, The Journal of Biological Chemistry.

Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor–Null Mice

M. Linton, S. Fazio, Y. Su, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Expression of Hepatocyte Growth Factor/Scatter Factor, Its Receptor, c-met, and Tissue-Type Plasminogen Activator during Development of the Murine Olfactory System

D. Thewke, N. Seeds, 1996, The Journal of Neuroscience.

The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.

D. Thewke, Makenzie L. Fulmer, 2018, Cardiovascular & hematological disorders drug targets.

Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis

A. Agrawal, Sanjay K. Singh, D. Thewke, 2020, Frontiers in Immunology.

Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis ** This work was supported by the National Institutes of Health (NIH) grant HL085137 (D.P.T). Published, JLR Papers in Press, July 9, 2008.

N. E. Buckley, D. Thewke, N. Freeman-Anderson, 2008, Journal of Lipid Research.

Isolation of a Somatic Cell Mutant Resistant to the Induction of Apoptosis by Oxidized Low Density Lipoprotein*

A. Rusiñol, D. Thewke, M. Sinensky, 2000, The Journal of Biological Chemistry.

Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2.

D. Thewke, Courtney D Netherland, 2010, Biochemical and biophysical research communications.

Deficiency of Ataxia-Telangiectasia Mutated Kinase Modulates Functional and Biochemical Parameters of the Heart in Response to Western-type Diet.

Suman Dalal, Mahipal Singh, D. Thewke, 2021, American journal of physiology. Heart and circulatory physiology.